Bellevue Life Sciences Stock Total Asset
| BLACDelisted Stock | 3.01 0.88 22.62% |
Bellevue Life Sciences fundamentals help investors to digest information that contributes to Bellevue Life's financial success or failures. It also enables traders to predict the movement of Bellevue Stock. The fundamental analysis module provides a way to measure Bellevue Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bellevue Life stock.
Bellevue |
Bellevue Life Sciences Company Total Asset Analysis
Bellevue Life's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Bellevue Life Total Asset | 36.63 M |
Most of Bellevue Life's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bellevue Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
CompetitionBased on the latest financial disclosure, Bellevue Life Sciences has a Total Asset of 36.63 M. This is 99.99% lower than that of the Capital Markets sector and significantly higher than that of the Financials industry. The total asset for all United States stocks is 99.88% higher than that of the company.
Bellevue Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bellevue Life's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bellevue Life could also be used in its relative valuation, which is a method of valuing Bellevue Life by comparing valuation metrics of similar companies.Bellevue Life is currently under evaluation in total asset category among its peers.
Bellevue Fundamentals
| Return On Asset | -0.0301 | |||
| Current Valuation | 8.75 M | |||
| Shares Outstanding | 2.32 M | |||
| Shares Owned By Insiders | 58.65 % | |||
| Shares Owned By Institutions | 8.31 % | |||
| Number Of Shares Shorted | 55 | |||
| Price To Book | 0.47 X | |||
| EBITDA | 944.59 K | |||
| Net Income | 403.78 K | |||
| Total Debt | 4.11 M | |||
| Book Value Per Share | (1.42) X | |||
| Cash Flow From Operations | (818.77 K) | |||
| Short Ratio | 0.01 X | |||
| Earnings Per Share | (0.09) X | |||
| Market Capitalization | 6.98 M | |||
| Total Asset | 36.63 M | |||
| Retained Earnings | (3.91 M) | |||
| Working Capital | (2.02 M) | |||
| Net Asset | 36.63 M |
About Bellevue Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bellevue Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bellevue Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bellevue Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Bellevue Stock
If you are still planning to invest in Bellevue Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellevue Life's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |